Panel discussion on immune therapies for lymphoma - CAR T-cell therapy and the question of cure
Anas Younes et al.
T-SPOT assay for tuberculosis and cytomegalovirus - benefits, results and next steps
Safety and efficacy of venetoclax plus LDAC in treatment-naive AML patients aged ≥ 65 years
Current research on coagulopathy in APL
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL